The company is known as Merck in the United States and Canada. Everywhere else, we are known as MSD. Merck & Co., Inc. is the legal name and is listed on the New York Stock Exchange under the symbol "MRK."

Merck is an innovative, global healthcare leader that is committed to improving health and well-being around the world.

Our product offering categories include heart and respiratory health, infectious diseases and women's health. We continue to focus our research on conditions that affect millions of people around the world - diseases like Alzheimer's, diabetes and cancer - while expanding our strengths in areas like vaccines and biologics.

We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them.

At Merck, we're applying our global reach, financial strength and scientific excellence to do more of what we're passionate about: improving health and improving lives.

Merck. Be well.

Type
Public
HQ
Kenilworth, US
Founded
1891
Employees
68,000 (est)-2%
Merck was founded in 1891 and is headquartered in Kenilworth, US

Key People at Merck

Kenneth Frazier

Kenneth Frazier

Chairman of the Board and Chief Executive Officer
Robert Davis

Robert Davis

Executive Vice President and Chief Financial Officer
Richard DeLuca

Richard DeLuca

Executive Vice President and President
Julie Gerberding

Julie Gerberding

Executive Vice President
Mirian Graddick-Weir

Mirian Graddick-Weir

Executive Vice President
Michael Holston

Michael Holston

Executive Vice President and General Counsel
Roger Perlmutter

Roger Perlmutter

Executive Vice President and President
Adam Schechter

Adam Schechter

Executive Vice President and President

Merck Locations

Kenilworth, US
Los Angeles, US
Hackensack, US
Des Moines, US
Virginia Beach, US
Ashland, US
Buffalo, US
Houston, US
Arlington, US
Wellington, NZ
San Francisco, US
Quebec, CA
Sydney, AU
Wien, AT
Minsk, BY
Brussels, BE
Sao Paulo, BR
Shanghai, CN
Paris, FR
Cincinnati, US

Merck Metrics

Merck Summary

Market capitalization

$166 B

Closing share price

$60.1
Merck's latest market capitalization is $166 B.

Merck Market Value History

Merck Online Presence

Merck News

Merck Company Life

You may also be interested in